Pictet Asset Management
AMED

Pictet Asset Management’s Amedisys AMED Stock Holding History

Pictet Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,089
Closed -$501K – 2032
2025
Q2 		$501K Buy
5,089
+392
+8% +$37.1K ﹤0.01% 1363
2025
Q1 		$435K Buy
4,697
+381
+9% +$35.1K ﹤0.01% 1420
2024
Q4 		$392K Hold
4,316
– – ﹤0.01% 1498
2024
Q3 		$417K Hold
4,316
– – ﹤0.01% 1423
2024
Q2 		$396K Hold
4,316
– – ﹤0.01% 1381
2024
Q1 		$398K Sell
4,316
-14,417
-77% -$1.35M ﹤0.01% 1410
2023
Q4 		$1.78M Buy
18,733
+14,642
+358% +$1.37M ﹤0.01% 904
2023
Q3 		$382K Buy
+4,091
New +$378K ﹤0.01% 1356

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management's AMED Position: Q3 2025 in Review

Pictet Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 5,089 shares — an estimated $501K sold.

Pictet Asset Management first reported a position in AMED in Q3 2023 and held it in 8 quarters. The position peaked at $1.78M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Pictet Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Pictet Asset Management sold 5,089 Amedisys shares in Q3 2025, an estimated $501K.
  • Pictet Asset Management first reported a position in Amedisys in Q3 2023 and held it in 8 quarters.
  • Pictet Asset Management's Amedisys position peaked at $1.78M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Pictet Asset Management's 13F filing for Q3 2025, filed 18 Nov 2025.